In recent years, the UK has seen a gradual decline in the number of scientific publications in drug discovery. From 148.27 publications in 2024, the forecast suggests a downward trend to 117.41 by 2028. Year-on-year growth rates indicate a consistent decrease, with an average annual contraction of scientific output. This trend may reflect shifting research focus, reduced funding, or increased competition from other countries. Given the strong scientific base in the UK, the decline raises concerns about future innovation in drug discovery.
Future trends to monitor include the impact of AI in drug research, increased collaborations with biotech firms, and potential shifts in government funding policies. These factors could influence the trajectory of scientific output in the coming years, potentially mitigating declines or even reversing the current trend.
